Sally Gu

Sally Gu

Washington, D.C.

Email [email protected]​

Phone +1 202 637 6856

Fax +1 202 637 5910


Practice groupGlobal Regulatory

Sally Gu advises clients on Food and Drug Administration (FDA) advertising and promotion issues, compliance with current good manufacturing practices (cGMP), life cycle management, and product development issues. 

She routinely advises pharmaceutical companies on pre-launch and post-marketing advertising and promotion issues and has served on multiple promotional review committees.  She also assists pharmaceutical clients with responses to FDA enforcement actions and related government investigations, and advises on FDA regulatory issues arising in corporate transactional matters and filings with the Securities and Exchange Commission (SEC).

While at University of Michigan Law School, Sally was a Notes Editor for the Michigan Law Review, and the President of the Michigan Health Law Organization.

In addition to assisting clients in the life sciences and health care industry, Sally is also active in the firm's Pro Bono practice.

Education and admissions


J.D., University of Michigan Law School, cum laude, 2018

B.A., The University of Chicago, general honors, 2014

Bar admissions and qualifications

District of Columbia


Representative experience

Counsel numerous pharmaceutical companies on pre-launch and post-marketing activities, including experience on promotional review committees.

Conduct internal audits for pharmaceutical companies of promotional materials, promotional review processes and investigator initiated study programs.

Assist multiple pharmaceutical companies in responding to FDA enforcement letters, Form FDA 483 inspectional observations, and related government investigations.

Loading data